PathGroup Acquires SkinDx

June 16, 2021

PathGroup, a Pritzker Private Capital‑backed pathology services provider based in Nashville, Tenn., has acquired SkinDx, a dermatopathology laboratory headquartered in Birmingham, Alabama. The transaction expands PathGroup’s dermatopathology capabilities and regional presence across the Southeast, Midwest and Mid‑Atlantic, and brings SkinDx access to PathGroup’s molecular and clinical pathology services.

Buyers
PathGroup
Targets
SkinDx
Platforms
PathGroup
Location
Alabama, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.